A new direct train service to a sunny European destination is planned for St Pancras International as part of its expansion. New expansion plans for St Pancras International are set to triple ...

London St. Pancras, Britain’s only international train station, is working with the Channel Tunnel on opening up more services to France and planning new routes to Germany and Switzerland.

Could the departure boards from London St Pancras International see new destinations? That is the hope of station and rail link operator London St Pancras Highspeed and the owners of the Channel ...

Plans put forward for works at London St Pancras train station will see more space created for international services, and the number of passengers heading to the continent triple, The Times reports.

Londoners could soon use St Pancras station to travel to France, Germany, Italy and Switzerland under expansion plans. Direct train routes to the European destinations could triple the station's ...

Queuing at St Pancras was never the most pleasant aspect of taking a Eurostar train from London to the continent. And then came Brexit and more long-winded border procedures. But change is afoot.

A deal between London St Pancras High Speed and Eurotunnel will “lay the foundations for increased cross-Channel rail traffic.” The company in charge of St Pancras International is luring in ...

New direct train routes from London to Germany, Switzerland and France could open as part of plans to boost passenger numbers at St Pancras station. London St Pancras Highspeed, which owns the ...

Hyperinsulinemia is when insulin levels in the blood are higher than usual. The pancreas makes insulin, a hormone that helps regulate blood sugar levels. Insulin allows the body to use and absorb ...

London St Pancras Highspeed, the company responsible for the station, hopes a redesigned terminal could attract new railway operators to compete with Eurostar, reported the Times. It has agreed to ...

Balachandran says. “If you can do this in pancreas cancer, theoretically you may be able to develop therapeutic vaccines for other cancer types.” Dr. Balachandran’s team in the OCCV aims to innovate ...